SenesTech (SNES) AI Stock Analysis

• Market Cap: $10.18M
• Dividend Yield: N/A
• Average Volume (3M): 66.03K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.68
• Revenue Growth: 39.37%
• EPS Growth: 69.81%
• Country: US
• Employees: 23
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): -0.35
• Shares Outstanding: 5,303,426
• 10 Day Avg. Volume: 49,700
• 30 Day Avg. Volume: 66,031
• PEG Ratio: 0.14
• Price to Book (P/B): 7.33
• Price to Sales (P/S): 31.57
• P/FCF Ratio: -11.91
• Enterprise Value/Market Cap: 0.48
• Enterprise Value/Revenue: 2.22
• Enterprise Value/Gross Profit: 3.55
• Enterprise Value/Ebitda: -0.77
• 1Y Price Target: $10.00
• Price Target Upside: 464.97% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): -1.11
• Revenue Forecast (FY): $4.57M

• Rating: 45 Neutral
• Price Target: $2.00 ▲(12.99% Upside)
• Action: Reiterated Date: 03/14/26
• Date: Action: Reiterated 03/14/26

The score is constrained primarily by persistent losses and ongoing negative free cash flow, alongside a weak technical trend with the stock trading below major moving averages. The earnings call provided a meaningful offset via improved margins, strong e-commerce momentum, and growth-focused guidance supported by a solid cash balance, but valuation remains difficult to support given negative earnings and no dividend yield data.

Positive Factors

Improved gross margin

A sustained gross margin near 62% signals durable unit economics driven by product mix and channel shift. Higher margins provide structural capacity to invest in growth, fund marketing and retail expansion, and narrow reliance on external financing if revenue trends continue, improving long-term scalability.

E-commerce acceleration

Rapid expansion of owned e‑commerce is structurally positive: direct channels increase margin capture, improve customer data and repeat purchase economics, and scale with lower incremental cost than field sales. Controlling Amazon listings reduces dependency on third parties and supports durable revenue growth.

Cash runway

A cash balance of $8.6M provides near-term runway to execute municipal pilots, retail rollout preparation, and international launches. Coupled with manageable reported leverage, this liquidity reduces immediate financing pressure and supports strategic initiatives while execution risk is resolved.

Negative Factors

Persistent net losses

Very large negative net margins indicate the business remains unprofitable despite revenue growth and margin improvement. Sustained GAAP losses erode equity, limit reinvestment capacity, and raise dependence on financing; absent continued margin gains and scale, profitability risks remain material.

Ongoing cash burn

Negative operating and free cash flow show losses are translating into real cash outflows. Continued cash burn constrains ability to fund retail expansion, municipal deployments, and international regulatory processes without external capital, increasing dilution or liquidity risk over the medium term.

Leadership transition risk

A CEO retirement during a phase of commercialization, retail onboarding and regulatory approvals creates execution risk. Transition may slow strategic decisions, distract management, and affect stakeholder confidence; retention payments and option acceleration also have cash and governance implications.

SenesTech Business Overview & Revenue Model

Company Description

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

How the Company Makes Money

SenesTech makes money primarily by selling its rodent fertility control products (notably ContraPest) through commercial distribution and direct sales channels. Revenue is generated from product purchases by customers such as municipalities, pest management professionals, and commercial or industrial operators seeking ongoing rodent control solutions; because fertility control is typically part of a sustained management program, repeat purchasing can be an important contributor when deployments continue over time. The company may also generate revenue through distributor/partner channels that resell the product and through supply arrangements that support broader market coverage. Detailed quantitative breakdowns of revenue by customer segment, pricing, or specific contract values are null.

SenesTech Financial Statement Overview

Summary

Improving gross margin (~62% TTM) and manageable leverage (debt-to-equity ~0.28) are positives, but profitability and cash generation remain very weak with deeply negative net margins (TTM net margin ~-287%) and continued cash burn (TTM operating cash flow about -$5.75M; free cash flow about -$5.89M).

Income Statement

Revenue has expanded materially over the last several years (from ~$0.26M in 2020 to ~$1.86M in 2024 and ~$2.22M in TTM (Trailing-Twelve-Months)), but the latest period shows a sharp revenue decline (TTM revenue growth of -3.477). Gross margin has improved meaningfully (negative in 2020 to ~62% in TTM), indicating better unit economics and product mix. However, profitability remains very weak: operating and net margins are deeply negative in every period, with TTM net margin around -287%, reflecting a cost structure that is still far too large relative to the revenue base.

Balance Sheet

Leverage appears manageable on the latest snapshot, with TTM debt-to-equity at ~0.28, suggesting debt is not the primary balance sheet pressure. At the same time, shareholder returns are heavily negative (TTM return on equity around -83%), consistent with sustained losses. Equity and assets are higher in TTM versus 2024, but the core weakness is that ongoing losses continue to erode economic value and could raise future financing risk if profitability does not improve.

Cash Flow

Cash generation remains a key concern: operating cash flow and free cash flow are negative across all periods, including TTM (operating cash flow about -$5.75M; free cash flow about -$5.89M). While cash burn has improved versus 2022–2023 and free cash flow shows positive growth in TTM, the business is still consuming substantial cash relative to its revenue base. Free cash flow is roughly in line with net losses (TTM free cash flow to net income ~1.03), indicating losses are translating into real cash outflows rather than being largely non-cash.

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	2.22M	1.86M	1.19M	1.02M	576.00K
Gross Profit	1.39M	1.00M	539.00K	464.00K	220.00K
EBITDA	-6.37M	-6.01M	-7.57M	-9.51M	-7.95M
Net Income	-6.38M	-6.18M	-7.71M	-9.70M	-8.27M
Balance Sheet
Total Assets	12.84M	3.28M	7.29M	6.78M	11.50M
Cash, Cash Equivalents and Short-Term Investments	8.57M	1.31M	5.39M	4.78M	9.33M
Total Debt	2.68M	262.00K	406.00K	359.00K	555.00K
Total Liabilities	3.27M	767.00K	942.00K	1.50M	1.47M
Stockholders Equity	9.57M	2.51M	6.35M	5.28M	10.04M
Cash Flow
Free Cash Flow	-5.89M	-6.12M	-7.71M	-8.75M	-7.88M
Operating Cash Flow	-5.75M	-6.03M	-7.57M	-8.58M	-7.78M
Investing Cash Flow	-1.10M	-56.00K	-149.00K	-170.00K	-99.00K
Financing Cash Flow	13.12M	2.00M	8.34M	4.20M	13.56M

SenesTech Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1.77
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SNES, the sentiment is Negative. The current price of 1.77 is below the 20-day moving average (MA) of 2.14, below the 50-day MA of 2.07, and below the 200-day MA of 3.46, indicating a bearish trend. The MACD of -0.05 indicates Positive momentum. The RSI at 38.26 is Neutral, neither overbought nor oversold. The STOCH value of 18.46 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SNES.

SenesTech Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
FSI	61 Neutral	$70.82M	-60.48	4.98%	―	0.18%	-54.25%
NTIC	57 Neutral	$78.21M	73.75	0.02%	1.33%	-0.97%	-99.67%
LOOP	56 Neutral	$65.26M	-4.53	71.64%	―	11013.00%	39.85%
SNES	45 Neutral	$10.18M	-1.55	-77.79%	―	39.37%	69.81%
GURE	43 Neutral	$6.41M	-0.05	-43.37%	―	61.85%	49.02%

SenesTech Corporate Events

SenesTech Announces CEO Retirement and Interim Leadership Transition

On January 22, 2026, SenesTech announced that President and CEO Joel L. Fruendt plans to retire from the company and its board by the earlier of June 30, 2026 or the appointment of a new chief executive, under a separation agreement that provides salary continuation through mid-December 2026, health insurance coverage through the end of 2026, and accelerated vesting of his stock options. On January 26, 2026, the board named director Jamie Bechtel as Interim Executive Chair with an annual compensation of $247,500 for this role, signaling an orderly leadership transition designed to provide governance continuity while the company searches for Fruendt’s successor, with potential implications for strategic direction and stakeholder confidence during the changeover period.

The most recent analyst rating on (SNES) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on SenesTech stock, see the SNES Stock Forecast page.